Professor Zadok presented the initial results following enrollment of 15 subjects in EpiTech’s First in Human Trial at the 2019 ASCRS.

The initial results are promising and the effect of ocular magnetic neurostimulation demonstrate clinically significant improvement in both signs and symptoms of Dry Eye Disease. Enrollment in the FIH Trial is due to continue.